Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Godfraind

Showing results (231-240 of 240) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 240 results.
Cardiovascular Research|April 16, 1998
Thyroid status and postnatal changes in subsarcolemmal distribution and isoform expression of rat cardiac dihydropyridine receptorsM Wibo, O Feron, L Zheng, et al.
Pharmacological Research Communications|March 1, 1986
Inhibition of the erythrocyte Na+, K+-pump by mammalian lignansP Braquet, N Senn, J P Robin, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studiesT Godfraind, S Salomone, C Dessy, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|July 1, 1985
Effects of tabernanthine on calcium and catecholamine stimulated contractions of isolated vascular and cardiac muscleN Hajo-Tello, C Dupont, J Wepierre, et al.
Hypertension (Dallas, Tex. : 1979)|December 22, 1999
Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic bandingP E Massart, J Donckier, J Kyselovic, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 18, 1999
Functional reduction and associated cellular rearrangement in SHRSP rat basilar arteries are affected by salt load and calcium antagonist treatmentS M Arribas, R Costa, S Salomone, et al.
British Journal of Pharmacology|December 10, 1998
The action of calcium channel blockers on recombinant L-type calcium channel alpha1-subunitsN Morel, V Buryi, O Feron, et al.
Arzneimittel-Forschung|February 1, 1996
Investigation of the positive inotropic action of 6,7-dimethoxy-3-cyano-3,4-dihydrocarbostyrilR Ferrini, G Miragoli, M L Calabi, et al.
Pharmacological Reviews|June 1, 1994
International Union of Pharmacology Committee on Receptor Nomenclature and Drug ClassificationP M Vanhoutte, E A Barnard, G J Cosmides, et al.
Stroke|September 2, 1999
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive ratsC Napoli, S Salomone, T Godfraind, et al.
Pageof 24

Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
Cardiovascular Research|April 16, 1998
Thyroid status and postnatal changes in subsarcolemmal distribution and isoform expression of rat cardiac dihydropyridine receptorsM Wibo, O Feron, L Zheng, et al.
Pharmacological Research Communications|March 1, 1986
Inhibition of the erythrocyte Na+, K+-pump by mammalian lignansP Braquet, N Senn, J P Robin, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studiesT Godfraind, S Salomone, C Dessy, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|July 1, 1985
Effects of tabernanthine on calcium and catecholamine stimulated contractions of isolated vascular and cardiac muscleN Hajo-Tello, C Dupont, J Wepierre, et al.
Hypertension (Dallas, Tex. : 1979)|December 22, 1999
Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic bandingP E Massart, J Donckier, J Kyselovic, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 18, 1999
Functional reduction and associated cellular rearrangement in SHRSP rat basilar arteries are affected by salt load and calcium antagonist treatmentS M Arribas, R Costa, S Salomone, et al.
British Journal of Pharmacology|December 10, 1998
The action of calcium channel blockers on recombinant L-type calcium channel alpha1-subunitsN Morel, V Buryi, O Feron, et al.
Arzneimittel-Forschung|February 1, 1996
Investigation of the positive inotropic action of 6,7-dimethoxy-3-cyano-3,4-dihydrocarbostyrilR Ferrini, G Miragoli, M L Calabi, et al.
Pharmacological Reviews|June 1, 1994
International Union of Pharmacology Committee on Receptor Nomenclature and Drug ClassificationP M Vanhoutte, E A Barnard, G J Cosmides, et al.
Stroke|September 2, 1999
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive ratsC Napoli, S Salomone, T Godfraind, et al.
Pageof 24